Research underpins part of the recently executed license and collaboration agreement to develop, manufacture and commercialize Navacim™ therapeutics for treatment of gastrointestinal inflammatory diseases, including autoimmune liver disease Article published in Nature Communications BURLINGAME, Calif. & CALGARY, Alberta–(BUSINESS WIRE)–Parvus Therapeutics, a biopharmaceutical company focused on the development of disease-specific immunoregulatory medicines to treat autoimmune diseases … [Read more…]

“Behavox Voice” Capabilities Recognized with “Best Use of AI for Voice Biometrics” Designation in Prestigious Annual Awards Program NEW YORK–(BUSINESS WIRE)–Behavox, an enterprise People Analytics software company, today announced that its recently introduced Behavox Voice platform has been selected as the winner of the “Best Use of AI for Voice Biometrics” from AI Breakthrough, a … [Read more…]

CPS selects Cureatr to provide medication management software to streamline and improve the delivery of telepharmacy services. NEW YORK–(BUSINESS WIRE)–#healthIT–Today, Cureatr announced that Comprehensive Pharmacy Services (CPS), the nation’s largest hospital and health system pharmacy services provider, has selected Cureatr Meds 360° medication management solution to help support their telepharmacy division. Meds 360° will provide … [Read more…]

Vicks® ZzzQuil™ Helps Americans Sleep with New Options CINCINNATI–(BUSINESS WIRE)–Getting a good night’s sleep is hard to come by these days, especially when the daily stresses of life keep you up. In fact, a survey by Harris Poll on behalf of Vicks® ZzzQuil™ found that two-thirds of Americans say they have trouble falling asleep at … [Read more…]

CHARLESTON, S.C. & OAKDALE, Minn.–(BUSINESS WIRE)–Veravas, Inc., an emerging diagnostic company, appointed eight members to its Advisory Board. The board is comprised of leaders in diagnostics, healthcare, and business development who will provide counsel and guidance to Veravas. Members include Jeremy Coote, Richard Creager, Ph.D., Claude Dufresne, Ph.D., Phillip Levy, M.D., Blackford Middleton, M.D., Chris … [Read more…]

Leading South Korean biopharmaceutical modernizes trial operations to maintain inspection readiness and have a comprehensive view of study status PLEASANTON, Calif.–(BUSINESS WIRE)–#activeTMF—Veeva Systems (NYSE:VEEV) today announced that Celltrion, one of the top South Korean biopharmaceutical companies, implemented Veeva Vault eTMF to improve oversight across its trial master file (TMF) processes and achieve greater compliance. Vault … [Read more…]

BOSTON–(BUSINESS WIRE)–Decibel Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for hearing loss and balance disorders, today announced the appointment of Christine Poon to its board of directors. Ms. Poon has spent more than 30 years in leadership roles in the biopharmaceutical industry. She currently serves as executive in residence of The Max M. Fisher … [Read more…]

Navigant’s customer experience, value, expertise, and flexibility in contracting and executing services highlighted in reports, which are based on client feedback CHICAGO–(BUSINESS WIRE)–$NCI–Navigant (NYSE: NCI) has been rated as the top performer for revenue cycle outsourcing (RCO) in KLAS’ 2019 Outsourced Revenue Cycle Services report. In addition, Navigant is a top performer for client satisfaction … [Read more…]

IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. will host a congressional briefing today titled “Rx for Success – Part II” with a panel that includes U.S. Rep. Angie Craig (D-Minn) and experts from Allina Health and Lifespan. The briefing — the second in a series highlighting how hospital providers nationwide are managing and mitigating rising prescription drug costs … [Read more…]

— Compassionate use results to be presented at UMDF’s Mitochondrial Medicine 2019 symposium — — Minovia initiates U.S. operations in Cambridge, Mass. — — John Cox named Executive Chairman — CAMBRIDGE, Mass. & HAIFA, Israel–(BUSINESS WIRE)–Minovia Therapeutics today announced dosing of the first patient in a Phase I/II clinical trial of the company’s Mitochondrial Augmentation … [Read more…]